AORT vs CBLL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AORT · Artivion$18.16 ▼ 2.00%
CBLL · Ceribell$27.39 ▲ 6.37%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AORT -60.4%
- CBLL +71.1%
Head to head
| Metric | AORT | CBLL |
|---|---|---|
| Price | $18.16 | $27.39 |
| Change today | ▼ 2.00% | ▲ 6.37% |
| Market cap | $886.02M | $1.06B |
| Return, 3 months | -32.5% | +14.4% |
| Return, year to date | -60.2% | +24.9% |
| Return, 1 year | -59.8% | +79.5% |
| P/E (TTM) | – | – |
| P/B | 2.0 | 9.0 |
| P/E percentile vs own 5y | 45th | 57th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +9.2% | +29.9% |
| Net profit growth (YoY) | -221.9% | -58.6% |
| Gross margin | 63.3% | 89.3% |
| Operating margin | 1.6% | -69.8% |
| Net margin | -3.6% | -68.0% |
| Return on equity | -4.0% | -52.5% |
| Analyst target vs. price | +96.9% | +15.9% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 33 | 56 |
| 30-day volatility | 82.5% | 59.7% |
| Max drawdown, 1 year | -61.9% | -30.5% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CBLL is the largest of the group by market value.
- CBLL has returned the most over the past year.
- CBLL is growing revenue fastest.
- AORT keeps the most profit per dollar of sales.
- CBLL has been the calmest stock over the last 30 days.